값Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTM투자 활동으로 인한 현금15.42 M23.62 M-54.85 M38.36 M-1.68 M-19.49 M-37.66 M재무활동으로 인한 현금-1.2 M0371 K-361 K-4.01 M-10.36 M-14.36 M잉여 현금 흐름-1.91 M-3.52 M-3.54 M-1.63 M-468 K-2.92 M-8.55 M
Oramed Pharmaceuticals Inc. - Common Stock
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.